Related Experiment Videos
[Cardiovascular pharmacotherapy in the aged].
1Innere Medizin III, Medizinische Klinik und Poliklinik, Universitätskliniken des Saarlandes, Homburg. magnus@baumhaekel.de
Der Internist
|December 16, 2003
Summary
Cardiovascular disease treatment in the elderly is complex due to age-related physiological changes and multiple medications. This review covers effective pharmacotherapy and drug characteristics for older patients with heart conditions.
Area of Science:
- Geriatric Cardiology
- Clinical Pharmacology
- Cardiovascular Medicine
Context:
- Cardiovascular diseases (CVD) prevalence rises with age.
- Elderly patients present unique challenges in CVD management.
- Polypharmacy is common, increasing drug-interaction risks.
Purpose:
- To review current pharmacotherapy for CVD in the elderly.
- To discuss age-related pharmacokinetic and pharmacodynamic changes.
- To highlight challenges and considerations in treating elderly CVD patients.
Summary:
- Aging impacts drug absorption, distribution, metabolism, and excretion, affecting CVD treatment efficacy.
- Comorbidities often limit guideline-recommended CVD pharmacotherapy in older adults.
- This review examines frequently used cardiovascular drugs and their use in geriatric populations.
Impact:
- Provides insights for optimizing CVD pharmacotherapy in elderly patients.
- Aims to improve clinical decision-making for geriatric cardiology.
- Enhances understanding of drug interactions and management strategies in older adults with CVD.